TY - JOUR
T1 - Analytical techniques for multiplex analysis of protein biomarkers
AU - Van Gool, Alain
AU - Corrales, Fernado
AU - Čolović, Mirjana
AU - Krstić, Danijela
AU - Oliver-Martos, Begona
AU - Martínez-Cáceres, Eva
AU - Jakasa, Ivone
AU - Gajski, Goran
AU - Brun, Virginie
AU - Kyriacou, Kyriacos
AU - Burzynska-Pedziwiatr, Izabela
AU - Wozniak, Lucyna Alicja
AU - Nierkens, Stephan
AU - Pascual García, César
AU - Katrlik, Jaroslav
AU - Bojic-Trbojevic, Zanka
AU - Vacek, Jan
AU - Llorente, Alicia
AU - Antohe, Felicia
AU - Suica, Viorel
AU - Suarez, Guillaume
AU - t’Kindt, Ruben
AU - Martin, Petra
AU - Penque, Deborah
AU - Martins, Ines Lanca
AU - Bodoki, Ede
AU - Iacob, Bogdan Cezar
AU - Aydindogan, Eda
AU - Timur, Suna
AU - Allinson, John
AU - Sutton, Christopher
AU - Luider, Theo
AU - Wittfooth, Saara
AU - Sammar, Marei
N1 - Publisher Copyright:
© 2020, © 2020 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group.
PY - 2020/4/2
Y1 - 2020/4/2
N2 - Introduction: The importance of biomarkers for pharmaceutical drug development and clinical diagnostics is more significant than ever in the current shift toward personalized medicine. Biomarkers have taken a central position either as companion markers to support drug development and patient selection, or as indicators aiming to detect the earliest perturbations indicative of disease, minimizing therapeutic intervention or even enabling disease reversal. Protein biomarkers are of particular interest given their central role in biochemical pathways. Hence, capabilities to analyze multiple protein biomarkers in one assay are highly interesting for biomedical research. Areas covered: We here review multiple methods that are suitable for robust, high throughput, standardized, and affordable analysis of protein biomarkers in a multiplex format. We describe innovative developments in immunoassays, the vanguard of methods in clinical laboratories, and mass spectrometry, increasingly implemented for protein biomarker analysis. Moreover, emerging techniques are discussed with potentially improved protein capture, separation, and detection that will further boost multiplex analyses. Expert commentary: The development of clinically applied multiplex protein biomarker assays is essential as multi-protein signatures provide more comprehensive information about biological systems than single biomarkers, leading to improved insights in mechanisms of disease, diagnostics, and the effect of personalized medicine.
AB - Introduction: The importance of biomarkers for pharmaceutical drug development and clinical diagnostics is more significant than ever in the current shift toward personalized medicine. Biomarkers have taken a central position either as companion markers to support drug development and patient selection, or as indicators aiming to detect the earliest perturbations indicative of disease, minimizing therapeutic intervention or even enabling disease reversal. Protein biomarkers are of particular interest given their central role in biochemical pathways. Hence, capabilities to analyze multiple protein biomarkers in one assay are highly interesting for biomedical research. Areas covered: We here review multiple methods that are suitable for robust, high throughput, standardized, and affordable analysis of protein biomarkers in a multiplex format. We describe innovative developments in immunoassays, the vanguard of methods in clinical laboratories, and mass spectrometry, increasingly implemented for protein biomarker analysis. Moreover, emerging techniques are discussed with potentially improved protein capture, separation, and detection that will further boost multiplex analyses. Expert commentary: The development of clinically applied multiplex protein biomarker assays is essential as multi-protein signatures provide more comprehensive information about biological systems than single biomarkers, leading to improved insights in mechanisms of disease, diagnostics, and the effect of personalized medicine.
KW - mass spectrometry
KW - Multiplexing
KW - validation
UR - http://www.scopus.com/inward/record.url?scp=85085325196&partnerID=8YFLogxK
U2 - 10.1080/14789450.2020.1763174
DO - 10.1080/14789450.2020.1763174
M3 - Review article
C2 - 32427033
AN - SCOPUS:85085325196
SN - 1478-9450
VL - 17
SP - 257
EP - 273
JO - Expert Review of Proteomics
JF - Expert Review of Proteomics
IS - 4
ER -